W.J. Tu, Y. Xue, D. Nie, The prevalence and treatment of diabetes in China From 2013 to 2018. Jama 327, 1706 (2022)

Article  PubMed  Google Scholar 

M.E. Pfisterer, M.J. Zellweger, B.J. Gersh, Management of stable coronary artery disease. Lancet 375, 763–772 (2010)

Article  CAS  PubMed  Google Scholar 

J. Knuuti, W. Wijns, A. Saraste, D. Capodanno, E. Barbato et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur. Heart J. 41, 407–477 (2019)

Article  Google Scholar 

K.A.A. Fox, M. Metra, J. Morais, D. Atar, The myth of ‘stable’ coronary artery disease. Nat. Rev. Cardiol. 17, 9–21 (2020)

Article  CAS  PubMed  Google Scholar 

S.V. Arnold, D.L. Bhatt, G.W. Barsness, A.L. Beatty, P.C. Deedwania et al. Clinical management of stable coronary artery disease in patients with Type 2 diabetes mellitus: a scientific statement from the american heart association. Circulation 141, e779–e806 (2020)

Article  PubMed  Google Scholar 

E. Di Angelantonio, S. Kaptoge, D. Wormser, P. Willeit, A.S. Butterworth et al. Association of cardiometabolic multimorbidity with mortality. Jama 314, 52–60 (2015)

Article  PubMed  Google Scholar 

D.J. Holland, T.H. Marwick, B.A. Haluska, R. Leano, M.D. Hordern et al. Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus. Heart 101, 1061–1066 (2015)

Article  PubMed  Google Scholar 

L. Ernande, E. Audureau, C.L. Jellis, C. Bergerot, C. Henegar et al. Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus. J. Am. Coll. Cardiol. 70, 1704–1716 (2017)

Article  PubMed  Google Scholar 

P. Blomstrand, M. Engvall, K. Festin, T. Lindström, T. Länne et al. Left ventricular diastolic function, assessed by echocardiography and tissue Doppler imaging, is a strong predictor of cardiovascular events, superior to global left ventricular longitudinal strain, in patients with type 2 diabetes. Eur. Heart J. Cardiovasc. Imaging 16, 1000–1007 (2015)

PubMed  Google Scholar 

J.B. Echouffo-Tcheugui, S.K. Musani, A.G. Bertoni, A. Correa, E.R. Fox et al. Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study. Cardiovasc. Diabetol. 21, 89 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.A. Cavender, P.G. Steg, S.C. Smith Jr, K. Eagle, E.M. Ohman et al. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation 132, 923–931 (2015)

Article  PubMed  Google Scholar 

M.C. Thomas, M.E. Cooper, P. Zimmet, Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat. Rev. Nephrol. 12, 73–81 (2016)

Article  CAS  PubMed  Google Scholar 

M. Tonelli, P. Muntner, A. Lloyd, B.J. Manns, S. Klarenbach et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 380, 807–814 (2012)

Article  PubMed  Google Scholar 

E.L. Schiffrin, M.L. Lipman, J.F. Mann, Chronic kidney disease: effects on the cardiovascular system. Circulation 116, 85–97 (2007)

Article  PubMed  Google Scholar 

A. Solini, G. Penno, E. Bonora, C. Fondelli, E. Orsi et al. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. J. Am. Geriatr. Soc. 61, 1253–1261 (2013)

Article  PubMed  Google Scholar 

M. van der Velde, K. Matsushita, J. Coresh, B.C. Astor, M. Woodward et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 79, 1341–1352 (2011)

Article  PubMed  Google Scholar 

A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004)

Article  CAS  PubMed  Google Scholar 

C.P. Domingueti, L.M. Dusse, M. Carvalho, K.B. Gomes, A.P. Fernandes, Hypercoagulability and cardiovascular disease in diabetic nephropathy. Clin. Chim. Acta 415, 279–285 (2013)

Article  CAS  PubMed  Google Scholar 

M.J. Huang, R.B. Wei, Y. Wang, T.Y. Su, P. Di et al. Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ Open 7, e014294 (2017)

Article  PubMed  PubMed Central  Google Scholar 

P.M. Ambühl, R.P. Wüthrich, W. Korte, L. Schmid, R. Krapf, Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation. Nephrol. Dial. Transpl. 12, 2355–2364 (1997)

Article  Google Scholar 

J. Jankowski, J. Floege, D. Fliser, M. Böhm, N. Marx, Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143, 1157–1172 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

N. Koren-Morag, U. Goldbourt, D. Tanne, Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 67, 224–228 (2006)

Article  CAS  PubMed  Google Scholar 

A.G. Stack, Coronary artery disease and peripheral vascular disease in chronic kidney disease: an epidemiological perspective. Cardiol. Clin. 23, 285–298 (2005)

Article  PubMed  Google Scholar 

M.J. Adams, A.B. Irish, G.F. Watts, R. Oostryck, G.K. Dogra, Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function. Thromb. Res. 123, 374–380 (2008)

Article  CAS  PubMed  Google Scholar 

R.D. Rosenberg, Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am. J. Med. 87, 2s–9s (1989)

Article  CAS  PubMed  Google Scholar 

Z. Lu, F. Wang, M. Liang, SerpinC1/Antithrombin III in kidney-related diseases. Clin. Sci. 131, 823–831 (2017)

Article  CAS  Google Scholar 

G. Blavy, C. Kouame, [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii]. Nephrologie 15, 387–389 (1994)

CAS  PubMed  Google Scholar 

Z. Lu, D. Cheng, J. Yin, R. Wu, G. Zhang et al. Antithrombin III protects against contrast-induced nephropathy. EBioMedicine 17, 101–107 (2017)

Article  PubMed  PubMed Central  Google Scholar 

F. Wang, G. Zhang, Z. Lu, A.M. Geurts, K. Usa et al. Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury. Kidney Int. 88, 796–803 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S.G. Thompson, C. Fechtrup, E. Squire, U. Heyse, G. Breithardt et al. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Arterioscler Thromb. Vasc. Biol. 16, 357–362 (1996)

Article  CAS  PubMed  Google Scholar 

J. Lu, D. Niu, D. Zheng, Q. Zhang, W. Li, Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk. Biomed. Rep. 9, 517–522 (2018)

CAS  PubMed  PubMed Central  Google Scholar 

M. Uchiba, K. Okajima, K. Murakami, Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb. Res. 89, 233–241 (1998)

Article  CAS  PubMed  Google Scholar 

Y. Ma, J. Wang, J. Gao, H. Yang, Y. Wang et al. Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury. Thromb. Haemost. 113, 338–349 (2015)

Article  PubMed  Google Scholar 

C.M. Tu, C.H. Hsueg, K.M. Chu, S.M. Cheng, T.P. Tsao, Simultaneous thromboses of double coronary arteries in a young male with antithrombin III deficiency. Am. J. Emerg. Med. 27, 1169.e1163–1166 (2009)

Article  Google Scholar 

J. Chen, W. Zhang, Y.Q. Wu, H. Chen, J.F. Zhao, Correlations of acute myocardial infarction complicated by cerebral infarction with insulin resistance, adiponectin and HMGB1. Eur. Rev. Med. Pharm. Sci. 23, 4425–4431 (2019)

CAS  Google Scholar 

A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009)

Article  PubMed  PubMed Central  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group, KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 102, S1–s127 (2022)

Article  Google Scholar 

S.D. Navaneethan, S. Zoungas, M.L. Caramori, J.C.N. Chan, H.J.L. Heerspink et al. Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update. Ann. Intern. Med. 176, 381–387 (2023)

Article  PubMed  Google Scholar 

R.H. Kauffmann, J.J. Veltkamp, N.H. Van Tilburg, L.A. Van Es, Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am. J. Med. 65, 607–613 (1978)

Article  CAS